Get started
Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 ShsEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 ShsEli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs

Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsSeasonalsBonds

Live chart


Full chart

Key facts today


Eli Lilly's oral GLP-1 drug, orforglipron, met key goals in two phase 3 trials, showing significant weight loss, improved heart health, and better blood sugar control in diabetics.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪1,065.82 T‬ ARS
Dividend yield (indicated)
0.44%
Price to earnings Ratio (TTM)
75
Basic EPS (TTM)
300 ARS
Net income (FY)
‪9.70 T‬ ARS
Revenue (FY)
‪41.24 T‬ ARS
Shares float
—
Beta (1Y)
−0.15

About Eli Lilly and Company


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
David A. Ricks
Website
lilly.com
Headquarters
Indianapolis
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFTQS8
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Check out other big names from the same industry as LLY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


XS238628644
Eli Lilly and Company 1.625% 14-SEP-2043
Yield to maturity
5.68%
Maturity date
Sep 14, 2043
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.65%
Maturity date
Jun 15, 2044
LLY6153503
Eli Lilly and Company 5.65% 15-OCT-2065
Yield to maturity
5.41%
Maturity date
Oct 15, 2065
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047
Yield to maturity
5.36%
Maturity date
May 15, 2047
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065
Yield to maturity
5.35%
Maturity date
Feb 12, 2065
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.33%
Maturity date
Feb 9, 2064
US532457BU1
Eli Lilly and Company 4.15% 15-MAR-2059
Yield to maturity
5.33%
Maturity date
Mar 15, 2059
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.32%
Maturity date
Aug 14, 2064
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.31%
Maturity date
Feb 27, 2063
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054
Yield to maturity
5.26%
Maturity date
Aug 14, 2054
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053
Yield to maturity
5.26%
Maturity date
Feb 27, 2053

See all LLY bonds 

Sparks


Curated watchlists where LLY is featured.

See all sparks